Biotech Specialty Pharma

Pharminox

28 Stonebridge Rd
Steventon, Abingdon, OX13 6AU United Kingdom
Phone
Fax
Click for website

Research Sector Biotech Specialty Pharma

Summary Description Small molecule oncology research and development.

Management Peter Worrall, MA ACA, Chief Executive Officer; Professor Malcolm Stevens OBE, B.Pharm, PhD, DSc, DSc Hons (London), CChem., FRSC Chief Scientific Officer; Sue Barrowcliffe BSc, Non Executive Director; Dr Mario Polywka PhD, Non-Executive Director; Andrew Mackie, Non-Executive Director

Click here for Financial Data
Keywords: cancer, small, molecule, oncology, research, compounds, agents, hydrocarbon, dna, nucleus, cytochrome, electrophilic, phortress, ovarian, breast, renal, lung, platinum, inhibitors

Comment


Updated: Jun. 27, 2012


Description

Pharminox is committed to addressing unmet needs in cancer therapy through small molecule oncology research and development.......view more

Products / Services

Preclinical studies (in vitro and in vivo) have shown Phortress to be a potent anti-cancer agent particularly against types of ovarian, breast, renal and lung cancer cells.......view more

RELATED COMPANIES



0000-00-00-2722